BJ's Wholesale Club (BJ) Tops Q2 EPS by 8c
Get Alerts BJ Hot Sheet
Price: $83.82 -1.64%
Revenue Growth %: +10.0%
Financial Fact:
Preopening expenses: 333K
Today's EPS Names:
OCCI, MAYS, CRMT, More
Revenue Growth %: +10.0%
Financial Fact:
Preopening expenses: 333K
Today's EPS Names:
OCCI, MAYS, CRMT, More
Join SI Premium – FREE
BJ's Wholesale Club (NYSE: BJ) reported Q2 EPS of $1.09, $0.08 better than the analyst estimate of $1.01. Revenue for the quarter came in at $5.21 billion versus the consensus estimate of $5.15 billion.
GUIDANCE:
BJ's Wholesale Club sees FY2025 EPS of $3.75-$4.00, versus the consensus of $3.93.
- “As we look ahead, we remain confident in our ability to drive long-term growth and shareholder value led by our continued focus on executing our strategic priorities and delivering significant value to our members,” said Laura Felice, Executive Vice President, Chief Financial Officer, BJ's Wholesale Club. “With respect to our outlook, we continue to expect fiscal 2024 comparable club sales, excluding the impact of gasoline sales, to increase 1% to 2% year-over-year, with traffic and unit growth as well as a strong perishables business likely driving us to the higher end of the range. Our business model and long-term strategies have allowed us to invest in our value proposition to help our members stretch their dollar. As we do what’s right for our members, we expect our fiscal 2024 merchandise gross margins to remain approximately flat year-over-year. Finally, we continue to expect our fiscal 2024 adjusted EPS to range from $3.75 to $4.00, with our investments for the long term potentially driving us toward the low end of the range.”
For earnings history and earnings-related data on BJ's Wholesale Club (BJ) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Primoris cuts 2026 outlook on renewables cost overruns, COO exits
- A.O. Smith executive chairman to retire, CEO to assume chairman role
- MacroGenics to receive $24.5M milestone from Sanofi on FDA approval
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share